DeepMed Research

Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Not Applicable

Recruiting

Conditions: Skin Basal Cell Carcinoma

Interventions: Other: Educational Activity
Other: Patient Observation
Other: Best Practice
Other: Survey Administration

First Posted Date: 2024-08-06

Last Posted Date: 2025-04-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 200

Registration Number: NCT06539468

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

Not Applicable

Recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Acupressure Therapy
Other: Internet-Based Intervention
Other: Interview
Other: Medical Device Usage and Evaluation
Other: Questionnaire Administration

First Posted Date: 2024-06-04

Last Posted Date: 2024-10-16

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT06442891

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Early Phase 1

Recruiting

Conditions: Colorectal Neoplasia

Interventions: Drug: Omeprazole
Drug: Aspirin

First Posted Date: 2024-04-22

Last Posted Date: 2025-04-10

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 24

Registration Number: NCT06378398

Locations: 🇺🇸
The University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer

Phase 2

Not yet recruiting

Conditions: Urothelial Carcinoma

Interventions: Drug: Enfortumab vedotin
Drug: Pembrolizumab

First Posted Date: 2024-04-10

Last Posted Date: 2025-04-15

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 32

Registration Number: NCT06356155

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Phase 2

Active, not recruiting

Conditions: HPV-Related Carcinoma
Oropharynx Cancer

Interventions: Radiation: Radiation
Drug: Platinum based chemotherapy

First Posted Date: 2024-01-31

Last Posted Date: 2025-05-13

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 19

Registration Number: NCT06234748

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer
Postmenopausal

Interventions: Other: Acupressure

First Posted Date: 2024-01-29

Last Posted Date: 2025-05-08

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 50

Registration Number: NCT06228768

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Gilteritinib for the Treatment of ALK NSCLC

Phase 1

Recruiting

Conditions: Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Echocardiography
Drug: Gilteritinib
Procedure: Magnetic Resonance Imaging
Other: Questionnaire Administration

First Posted Date: 2024-01-26

Last Posted Date: 2025-02-25

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT06225427

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Breast Cancer Resiliency Through Exercise Program (B-REP)

Not Applicable

Recruiting

Conditions: Breast Cancer Female

Interventions: Other: Control Arm
Other: Individualized exercise program

First Posted Date: 2023-10-25

Last Posted Date: 2024-11-08

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 200

Registration Number: NCT06100263

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

Withdrawn

Conditions: Head and Neck Cancer

Interventions: Other: Survey

First Posted Date: 2023-10-23

Last Posted Date: 2025-03-07

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 200

Registration Number: NCT06094621

Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer

Not Applicable

Recruiting

Conditions: Thyroid Cancer

Interventions: Other: Usual Care
Other: CQUPLE

First Posted Date: 2023-10-10

Last Posted Date: 2024-12-19

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 70

Registration Number: NCT06073223

Locations: 🇺🇸
The University of Michigan Cancer Center, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy